A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Pennsylvania Cancer Specialists Research Institute - Gettysburg Cancer Center, Gettysburg

Thomas Jefferson University, Philadelphia

Virginia Cancer Specialists, Fairfax

Hospital Clínico San Carlos, Madrid

Hospital Universitario Quirónsalud Madrid, Madrid

O'Neal Comprehensive Cancer Center at the University of Alabama, Birmingham

SCRI Tennessee Oncology, Nashville

Cleveland Clinic - Taussig Cancer Center, Cleveland

Community Health Network Community Cancer Center South, Indianapolis

Community Health Network Community Cancer Center North, Indianapolis

University of Michigan Rogel Cancer Center, Ann Arbor

Barbara Ann Karmanos Cancer Institute, Detroit

Washington University, St Louis

The University of Texas MD Anderson Cancer Center, Houston

Precision NextGen Oncology, Los Angeles

Norris Comprehensive Cancer Center, Los Angeles

University of California, Los Angeles (UCLA), Los Angeles

City of Hope, Duarte

City of Hope - Orange County Lennar Foundation Cancer Center, Irvine

MemorialCare - Orange Coast Medical Center, Fountain Valley

Massachusetts General Hospital, Boston

Dana Farber Cancer Institute, Boston

Hospital Clinic de Barcelona, Barcelona

Sarah Cannon Research Institute London, London